Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gilead Sciences Inc Raises FY 2013 Net Product Sales Guidance


Tuesday, 29 Oct 2013 04:02pm EDT 

Gilead Sciences Inc announced that for fiscal 2013, it revised fiscal 2013 guidance, which it initially provided on February 4, 2013 and reiterated on July 25, 2013, now the Company expects net product sales to be between $10.300 billion to $10.400 billion. 

Company Quote

93.79
2.5 +2.74%
26 Dec 2014